Tripeptide antioxidant · Fact sheet

Glutathione

Also known as GSH · Reduced glutathione

Glutathione is an antioxidant made by the body. Small oral studies measured glutathione stores and skin pigmentation, but they do not establish broad detox, anti-aging, or disease-prevention benefits.

Not FDA approvedEarly human evidence

What is Glutathione?

Glutathione is made from three amino acids and participates in cellular antioxidant systems. Different forms and routes are not interchangeable evidence.

Benefits & claims

Skin appearance, energy, immune support, and detox claims are common interests. An increase in an antioxidant biomarker is not the same as a demonstrated health improvement.

What the evidence supports

  • Oral supplementation increased measured glutathione stores in one randomized study.
  • Pigmentation differences in the small skin trial were significant at only two of six measured sites. Broad wellness benefits remain unproven.
Research areas
  • Glutathione stores
  • Skin pigmentation
  • Oxidative-stress biomarkers

Dosage & frequency

Human study context

An oral study tested changes in glutathione stores. Those biomarker results do not establish an injectable wellness regimen.

Randomized oral supplementation study

54 nonsmoking adults

Amount
250 or 1,000 mg in separate study groups
Frequency
Daily for six months
Route studied or labeled
Oral

Body glutathione stores were studied; clinical wellness benefit was not established.

How to read these amounts

An approved regimen belongs to a specific product, indication, and population. A study regimen describes what researchers tested; it does not establish a prescription or a safe self-use protocol. Products, routes, and formulations are not interchangeable. A prescriber uses the full label and individual clinical circumstances.

Personal accounts may describe amounts, schedules and outcomes beyond clinical research. They do not establish a regimen. Read the reported experiences

Formulations, interactions & practical context

Formulation differences

  • Oral, liposomal, inhaled, and intravenous glutathione have different exposure and evidence.

Interactions & precautions

  • FDA reports adverse events associated with unsuitable glutathione ingredients used in sterile compounding.

What is still unresolved

  • Clinical benefit beyond biomarker changes, and repeated injectable safety, remain uncertain.

Side effects & risks

  • Small oral trials provide limited information about uncommon or long-term adverse effects.
  • FDA documented adverse events linked to endotoxin-contaminated compounded sterile products; oral findings cannot establish injectable safety.

This is a summary of the cited evidence, not a complete product label. A lack of human safety data does not establish safety.

Clinical research

Early human evidence

A 54-person trial measured glutathione stores over six months. A separate 60-person, four-week skin study found small and uneven pigmentation changes; neither establishes durable clinical wellness benefits.

Studies

Personal experiences

Reports describe what someone noticed. They cannot establish cause, typical results, or how often a side effect happens. Amounts and schedules describe the individual account, not an effective or safe dose. Product identity and strength may be unverified, and missing details are left explicit.

Explore 4 sourced accounts by reported effect.

Energy: reported experiences

Mixed account · personal report

Repeated insomnia without more daytime energy

An author described insomnia on several attempts and later clarified that they had not noticed more energy.

Reported use in this account

Product
Injectable product described as glutathione
Amount
100 mg, 20 mg and 10 mg on separate attempts
Frequency
Not specified clearly
Route
Injection; type not stated
Duration
Not specified clearly

This injectable-product account cannot be generalized to oral supplements. Product contents and other causes of insomnia were not verified.

Read the original account
Negative account · personal report

Marked fatigue after combined exposure

Another author described sudden pronounced fatigue and a brief unusual head sensation after glutathione, following MOTS-c earlier that day.

Reported use in this account

Product
Product described as glutathione
Amount
200 mg
Frequency
One reported administration
Route
Not specified clearly
Duration
One reported administration

Other exposures described: MOTS-c, reported at 1 mg earlier that day

MOTS-c was reported earlier the same day, so attribution is unclear. The description does not establish an administration route, and neither product contents nor symptoms were independently verified.

Read the original account

Approval status

Glutathione has no FDA-approved drug indication for the wellness uses discussed here. Supplement availability is not premarket FDA approval of effectiveness or safety.

Supplement research is not FDA drug approval

Approval covers the labeled product, use and population. A trial phase does not establish success; a stopped program is not ongoing research.

Open questions

  • Meaningful effects beyond antioxidant measurements
  • Durability of skin changes
  • Long-term safety and comparability across routes

Summary

Pigmentation differences in the small skin trial were significant at only two of six measured sites. Broad wellness benefits remain unproven.

Sources

Medical evidence and regulatory sources are listed here. Personal reports are linked separately in the experiences section.

  1. pubmedOral glutathione and body stores

    54-adult randomized trial measuring biomarkers, not disease prevention.

  2. pubmedOral glutathione and skin pigmentation

    60-person, four-week trial with site-dependent results.

  3. fdaFDA: glutathione sterile-product safety concerns

    Adverse-event investigation involving contaminated compounded products.

  4. fdaFDA: what approval means for supplements

    Dietary supplements are not approved by FDA for safety and effectiveness before marketing.

How we assess sources · Suggest a correction